The Economics of Life Sciences Patent Enforcement: Damages, Licensing, and Settlement

The Economics of Life Sciences Patent Enforcement: Damages, Licensing, and Settlement

View Session Speakers

A successful patent enforcement strategy begins well before a verdict—and requires more than proving infringement.

A strong patent position creates an opportunity for economic recovery, but realizing that value requires a series of consequential strategic and tactical decisions. From developing the damages case to negotiating a license or settlement, patent owners must align their legal arguments, economic evidence, and commercial objectives. Using the $1.25 billion settlement in the ViiV–Gilead dispute as a starting point, this panel will explore how life sciences companies can position themselves to successfully capture the value of their patented innovations.

The discussion will examine how litigation counsel and economists can coordinate discovery, technical expert work, and damages analysis early enough to strengthen both the trial presentation and negotiating position. Panelists will consider how infringement and validity risk, remaining patent term, competitive alternatives, eventual generic entry, and projected sales influence settlement decisions, while distinguishing the economics of a negotiated resolution from damages recoverable at trial. The conversation will also address when upfront payments, running royalties, or a combination best serve the patent owner’s commercial objectives—and which pivotal decisions can strengthen or undermine the ultimate recovery.